Mutations in ras proto‐oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Haematology

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.2001.02562.xPMID 11167822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

  1999cited by this paper
• A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.

  1999cited by this paper
• Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR 1 / P-Glycoprotein , MRP 1 , and LRP in Acute Myeloid Leukemia . A Southwest Oncology Group Study

  1999cited by this paper
• Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

  1999cited by this paper
• Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.

  1999influential reference
• Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursors.

  1999influential reference
• Prognostic Implication of FLT 3 and N-RAS Gene Mutations in Acute Myeloid Leukemia

  1999cited by this paper
• Expression analysis of multidrug resistance associated genes in neuroblastomas.

  1999cited by this paper
• The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.

  1999cited by this paper
• Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.

  1998cited by this paper
• Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.

  1998cited by this paper
• Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.

  1998cited by this paper
• Expression of lung resistance-related protein (LRP) in non-small cell lung carcinomas of smokers and non-smokers and its predictive value for doxorubicin resistance.

  1997cited by this paper
• N-ras gene point mutations in Brazilian acute myelogenous leukemia patients correlate with a poor prognosis.

  1997cited by this paper
• A novel method for direct and fluorescence independent determination of drug efflux out of leukemic blast cells.

  1997cited by this paper
• Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia

  1997cited by this paper
• Overlapping phenotypes of multidrug resistance among panels of human cancer‐cell lines

  1996cited by this paper
• Simple and sensitive detection of mutations in the ras proto-oncogenes using PNA-mediated PCR clamping.

  1996cited by this paper
• Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling.

  1996cited by this paper
• Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML.

  1996cited by this paper
• Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia.

  1996cited by this paper
• Expression of mdrl, mrp, topoisomerase IIα/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias

  1995cited by this paper
• Expression of drug resistance-associated mdr-1, GST pi, and topoisomerase II genes during cell cycle traverse.

  1995cited by this paper
• The drug resistance-related protein LRP is the human major vault protein

  1995cited by this paper
• Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.

  1995cited by this paper
• The Ras signaling pathway and the molecular basis of myeloid leukemogenesis

  1995cited by this paper
• Signaling pathways mediated by the mitogen‐activated protein (MAP) kinase kinase/MAP kinase cascade

  1994cited by this paper
• The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia.

  1994cited by this paper
• Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.

  1994cited by this paper
• Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs.

  1994cited by this paper
• Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukaemic K562 cells.

  1993cited by this paper
• Pathways of Ras function: connections to the actin cytoskeleton.

  1993cited by this paper
• Function and regulation of ras.

  1993cited by this paper
• Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

  1992cited by this paper
• Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.

  1991cited by this paper
• GM-CSF incubation prior to treatment with cytarabine or doxorubicin enhances drug activity against AML cells in vitro: a model for leukemia chemotherapy.

  1990cited by this paper
• N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.

  1990cited by this paper
• Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes.

  1990cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemia.

  1987cited by this paper

• Oncogenic Ras downregulates mdr1b expression through generation of reactive oxygen species

  2020influential citation
• Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation

  2015cites this paper
• Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma

  2015cites this paper
• Therapy-Related Acute Myeloid Leukemias

  2013cites this paper
• and no independent prognostic relevance as analysed in 1766 patients classification in acute myeloid leukemia (AML) has no correlation with age Multilineage dysplasia according to the World Health Organisation (WHO)

  2013cites this paper
• patients age and no independent prognostic relevance as analyzed in 1766 MLD according to the WHO classification in AML has no correlation with

  2013cites this paper
• Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemia

  2013cites this paper
• Targeting aberrant kinase activity in myeloid leukaemias

  2013cites this paper
• Referenzen des Kompetenznetzes „Akute und chronische Leukämien“

  2012cites this paper
• The T_T genotype within the NME1 promoter single nucleotide polymorphism −835 C/T is associated with an increased risk of cytarabine induced neurotoxicity in patients with acute myeloid leukemia

  2012cites this paper
• A NME1 promoter SNP predicts Ara-C associated neurotoxicity in AML patients.

  2011cites this paper
• miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.

  2011cites this paper
• Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia.

  2010cites this paper
• with acute myeloid leukemia ) is associated GFI1 ( Growth Factor Independence 1 A variant allele of

  2010cites this paper
• Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.

  2010cites this paper
• utational analysis of Kras codon 12 in blood samples of patients ith acute myeloid leukemia

  2010cites this paper
• The Prognostic Impact of K-RAS Mutations in Adult Acute Myeloid Leukemia Patients Treated with High Dose Cytarabine.

  2009cites this paper
• Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity

  2009cites this paper
• ORIGINAL ARTICLE The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia

  2009cites this paper
• Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.

  2009cites this paper
• The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia

  2009cites this paper
• SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival

  2009cites this paper
• Expression of ABCC-Type Nucleotide Exporters in Blasts of Adult Acute Myeloid Leukemia: Relation to Long-term Survival

  2009cites this paper
• Mechanisms of tumor resistance to EGFR-targeted therapies

  2009cites this paper
• Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia

  2008cites this paper
• MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients.

  2008cites this paper
• Cup-like acute myeloid leukemia: new disease or artificial phenomenon?

  2008cites this paper
• HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

  2008cites this paper
• A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.

  2007cites this paper
• Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation

  2007cites this paper
• Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.

  2007cites this paper
• Class I HDAC SNP analysis in healthy donors compared to AML patients

  2007cites this paper
• Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias.

  2007cites this paper
• ORIGINAL ARTICLE Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia

  2006cites this paper
• Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia

  2006cites this paper
• K‐ras mutations and N‐ras mutations in childhood acute leukemias with or without mixed‐lineage leukemia gene rearrangements

  2006cites this paper
• Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia

  2006cites this paper
• Oncogenes and Tumor Suppressor Genes in Therapeutic Resistance

  2006cites this paper
• Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

  2006cites this paper
• BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.

  2006cites this paper
• patients with acute myeloid leukemia ( AML ) mutations in 1485 adult NPM 1 Prevalence and prognostic impact

  2006cites this paper
• Activation of the RAS Pathway Is Predictive for a Chemosensitive Phenotype of Acute Myelogenous Leukemia Blasts

  2005cites this paper
• MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia

  2005cites this paper
• Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities.

  2005cites this paper
• The MDR1 (ABCB1) Gene Polymorphism and its Clinical Implications

  2004cites this paper
• A sensitive model for prediction of relapse in adult acute myeloid leukaemia with t(8;21) using white blood cell count, CD56 and MDR1 gene expression at diagnosis

  2004cites this paper
• ABCA 3 biology may give novel insight into mechanisms of drug resistance and leukemic blast cell physiology

  2004influential citation
• Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

  2004cites this paper
• Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemia.

  2004cites this paper
• Management of acute myelogenous leukemia in the elderly.

  2003cites this paper
• Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia

  2003cites this paper
• Multidrug resistance in hematological malignancy.

  2003cites this paper
• Immunophenotyping is an independent factor for risk stratification in AML

  2003cites this paper
• Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia

  2003cites this paper
• A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes

  2003cites this paper
• The Search for Optimal Treatment in Relapsed and Refractory Acute Myeloid Leukemia

  2002cites this paper
• MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.

  2002cites this paper
• Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.

  2002cites this paper
• Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.

  2002cites this paper
• Mdr1 Gene Expression and Mutations in Ras Proto-oncogenes in Acute Myeloid Leukemia

  2002cites this paper
• Ras Signaling Enhances the Activity of C/EBPα to Induce Granulocytic Differentiation by Phosphorylation of Serine 248*

  2002cites this paper
• The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia

  2002cites this paper
• Human Deep Tissue Infection with an Entomopathogenic Beauveria Species

  2002cites this paper
• Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

  2002cites this paper
• Acute Leukemias The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia

  2001cites this paper
• The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.

  2001cites this paper
• Oncotargets and Therapy Dovepress

  year unknowncites this paper
• Intensified double induction therapy with high dose mitoxantrone , etoposide , m-amsacrine and high dose araC for patients aged 61-65 years with acute myeloid leukemia

  year unknowncites this paper